These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1462980)

  • 21. End-state renal failure in diabetic nephropathy: pathophysiology and treatment.
    Schmitz O; Hansen HE; Orskov H; Mogensen CE; Posborg Petersen V
    Blood Purif; 1985; 3(1-3):120-39. PubMed ID: 3913447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group.
    Laffel LM; McGill JB; Gans DJ
    Am J Med; 1995 Nov; 99(5):497-504. PubMed ID: 7485207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Losartan in diabetic nephropathy.
    Perico N; Ruggenenti P; Remuzzi G
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):473-83. PubMed ID: 15225108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal factors influencing blood pressure threshold and choice of treatment for hypertension in IDDM.
    Mogensen CE; Hansen KW; Pedersen MM; Christensen CK
    Diabetes Care; 1991 Nov; 14 Suppl 4():13-26. PubMed ID: 1748053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved prognosis of diabetic nephropathy in type 1 diabetes.
    Andrésdóttir G; Jensen ML; Carstensen B; Parving HH; Hovind P; Hansen TW; Rossing P
    Kidney Int; 2015 Feb; 87(2):417-26. PubMed ID: 24918158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of blood pressure and antihypertensive treatment on incipient and overt nephropathy, retinopathy, and endothelial permeability in diabetes mellitus.
    Parving HH
    Diabetes Care; 1991 Mar; 14(3):260-9. PubMed ID: 2044441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical features and health-care costs of diabetic nephropathy.
    Narins BE; Narins RG
    Diabetes Care; 1988; 11(10):833-9. PubMed ID: 3073074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progression of chronic renal disease and diabetic nephropathy: a review of clinical studies and current therapy.
    Marinides GN
    J Med; 1993; 24(4-5):266-88. PubMed ID: 8258740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of treatment of arterial hypertension on renal function in patients with imminent and overt diabetic nephropathy].
    Czekalski S; Pynka S; Majkowska L; Andrysiak-Mamos E; Krzyzanowska-Swiniarska B
    Pol Arch Med Wewn; 1994; 92 Spec No():60-9. PubMed ID: 7731901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An economic analysis of captopril in the treatment of diabetic nephropathy. The Collaborative Study Group.
    Rodby RA; Firth LM; Lewis EJ
    Diabetes Care; 1996 Oct; 19(10):1051-61. PubMed ID: 8886549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies of cardiovascular and renal function in subclinical and manifest diabetic nephropathy.
    Berglund J
    Acta Med Scand Suppl; 1988; 722():1-69. PubMed ID: 3163465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic interventions for nephropathy in type I diabetes mellitus.
    Breyer JA
    Semin Nephrol; 1997 Mar; 17(2):114-23. PubMed ID: 9148377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predisposition to hypertension: risk factor for nephropathy and hypertension in IDDM.
    Barzilay J; Warram JH; Bak M; Laffel LM; Canessa M; Krolewski AS
    Kidney Int; 1992 Apr; 41(4):723-30. PubMed ID: 1513093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early diabetic nephropathy: assessment and potential therapeutic interventions.
    Rosenstock J; Raskin P
    Diabetes Care; 1986; 9(5):529-45. PubMed ID: 3533477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of hypertension and antihypertensive treatment on the course and prognosis of diabetic nephropathy.
    Parving HH
    J Hypertens Suppl; 1990 Dec; 8(7):S187-91. PubMed ID: 2095388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment.
    Rossing P; Tarnow L; Boelskifte S; Jensen BR; Nielsen FS; Parving HH
    Diabetes; 1997 Mar; 46(3):481-7. PubMed ID: 9032106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy.
    Mogensen CE; Christensen CK; Vittinghus E
    Diabetes; 1983 May; 32 Suppl 2():64-78. PubMed ID: 6400670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Relations between arterial hypertension and diabetic nephropathy].
    Passa P; Marre M; Leblanc H
    Presse Med; 1987 Dec; 16(44):2221-5. PubMed ID: 2963317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glomerular hemodynamic and structural alterations in experimental diabetes mellitus.
    O'Donnell MP; Kasiske BL; Keane WF
    FASEB J; 1988 May; 2(8):2339-47. PubMed ID: 3282959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal protection in diabetes--an emerging role for calcium antagonists.
    Parving HH; Tarnow L; Rossing P
    Cardiology; 1997; 88 Suppl 3():56-62. PubMed ID: 9397296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.